Biostatistics: can we produce more valid results from trials?
Cell cycle-dependent resistance or sensitivity to drugs and the importance of MITF genes in melanoma
ctDNA signatures to detect lung cancer
What's next in melanoma research on drug resistance?
BRIM-3 trial in melanoma: prognostic factors of overall survival and the issue of salvage therapies